share_log

赛隆药业(002898.SZ):获得化学原料药富马酸丙酚替诺福韦上市申请批准通知书

Cailong Pharmaceutical (002898.SZ): Obtained a notice of approval for the marketing application of the chemical raw material propofol tenofovir fumarate

Gelonghui Finance ·  Jun 3, 2024 15:44

On June 3rd, Glorious Pharmaceutical reported that Hunan Sailong Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Sailong Pharmaceutical Group (002898.SZ), recently obtained the approval notice for the listing application of propofol and tenofovir disoproxil fumarate as active pharmaceutical ingredients issued by the National Medical Products Administration. Propofol and tenofovir disoproxil fumarate are mainly used for the treatment of chronic hepatitis B in adults and adolescents.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment